Pradeep K Dhal

This inventor holds 40 USPTO granted patents and 32 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Antibody-Drug Conjugation. Top assignees: Genzyme Corporation, Geltex Pharmaceuticals, Inc., Sanofi. Active years: 1994-2024.

USPTO Granted Patents = 40 (Patent Applications = 32)

% Patents Active = 70.0

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 15)

Average Co-Inventor Count = 4.5

ph-index = 12

Forward Citations = 358(Granted Patents)

Location History:

Pasadena, CA (US) (1994)
Acton, MA (US) (1998 - 2006)
Westford, WA (US) (2008)
Westford, NJ (US) (2018)
Cambridge, MA (US) (2020 - 2021)
Westford, MA (US) (2001 - 2023)
Bridgewater, NJ (US) (2018 - 2024)

Company Filing History:

Geltex Pharmaceuticals, Inc.

Boehringer Ingelheim Animal Health USA Inc.

patents

6. 1 out of 4,624

California Institute of Technology

where one patent can have more than one assignee

Years Active: 1994-2024

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugation

Glycoengineering

Hyperglycosylated Polypeptides

Bile Acid Sequestrants

Prodrugs

Dual Agonists

Amine Functional Polyamides

Combination Therapy

Antimicrobial Compositions

Holographic Medium

Aryl Boronic Acids

Polydiallyamine

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12110338 - Site-specific antibody-drug conjugation through glycoengineering (2024-10-08),

2. 12071454 - Antigenic respiratory syncytial virus polypeptides (2024-08-27),

3. 11807690 - Hyperglycosylated binding polypeptides (2023-11-07),

4. 11267924 - Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes (2022-03-08),

5. 11141489 - Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid (2021-10-12),

6. 11130816 - Site-specific antibody-drug conjugation through glycoengineering (2021-09-28),

7. 10806797 - Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate (2020-10-20),

8. 10792367 - Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid (2020-10-06),

9. 10583154 - Multi-dose compositions containing an antimicrobial polyamide or octenidine preservative (2020-03-10),

10. 10494439 - Hyperglycosylated binding polypeptides (2019-12-03),

11. 10214589 - Site-specific antibody-drug conjugation through glycoengineering (2019-02-26),

12. 10131744 - Antimicrobial polyamide compositions and mastitis treatment (2018-11-20),

13. 10113032 - Amine functional polyamides (2018-10-30),

14. 9701753 - Hyperglycosylated binding polypeptides (2017-07-11),

15. 9580511 - Site-specific antibody-drug conjugation through glycoengineering (2017-02-28),

Title: The Innovative Journey of Pradeep K Dhal

Introduction: Pradeep K Dhal, a talented inventor based in Westford, MA (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Pradeep K Dhal holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Pradeep K Dhal has had a successful career marked by his ability to turn creative ideas into practical solutions. His work has not only improved existing technologies but has also paved the way for new advancements in various industries.

Collaborations: Throughout his career, Pradeep K Dhal has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His collaborative spirit and dedication to innovation have led to the development of cutting-edge products that have had a positive impact on society.

Conclusion: Pradeep K Dhal's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true visionary in the world of inventions. His work continues to inspire the next generation of inventors and serves as a testament to the power of creativity and perseverance in driving progress.